Previous close | 2.1000 |
Open | 2.1000 |
Bid | 1.3500 |
Ask | 2.4000 |
Strike | 300.00 |
Expiry date | 2024-12-20 |
Day's range | 2.1000 - 2.1000 |
Contract range | N/A |
Volume | |
Open interest | 5 |
Eli Lilly is seeking FDA approval to expand the uses for its weight-loss drug Zepbound to include sleep apnea.
Key Insights ResMed's estimated fair value is US$270 based on 2 Stage Free Cash Flow to Equity Current share price of...
IDEXX's (IDXX) supply chain operations bear the brunt of geopolitical instability, including the current war in Ukraine.